4.17 USD
↗ 0.12 (2.97%)AT CLOSE (AS OF 07:31 PM EDT)
Atea Pharmaceuticals, Inc. Common Stock
AVIRNASDAQ • USD
Market: CLOSED
Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades at $4.17 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, AVIR appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$4.04
High?$4.24
Low?$3.94
Prev. Close?$4.04
Volume?251.1K
Avg. Volume?304.8K
VWAP?$4.16
Rel. Volume?0.82x
Bid / Ask
Bid?$3.44 × 100
Ask?$5.70 × 100
Spread?$2.26
Midpoint?$4.57
Valuation & Ratios
Market Cap?324.0M
Shares Out?80.2M
Float?61.1M
Float %?76.2%
P/E Ratio?N/A
P/B Ratio?1.59
EPS?-$2.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Employees
55
Market Cap
324.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-10-30
Address
225 FRANKLIN STREET
BOSTON, MA 02110
Phone: (857) 284-8891
BOSTON, MA 02110
Phone: (857) 284-8891
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?26
Momentum?50
Short Sent.?46
Piotroski F-Score?0/9Weak
Altman Z-Score?1.72Distress
Confidence?60%Moderate
Short InterestVery High
Short % of Float?5.02%Elevated
Short Interest?3.1M
Days to Cover?10.7
Free Float61.1M
Avg Daily Volume287.2K
Settlement Date2026-10-15
Financial Health
Current Ratio?8.13Strong
Quick Ratio?8.13Strong
Cash Ratio?2.72Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.59CHEAP▾
Peers100
S&P85
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-81.0%WEAK▾
S&P3
ROA?-71.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-152073000
Enterprise Value?$247.5M
Fundamentals ratios updated end of day